EIC Accelerator

Substantial X-ray dose reduction capability of Kinepict Medical Imaging Tool is approved by the FDA

Substantial x-ray dose reduction capability of the Kinepict Medical Imaging Tool is reviewed and approved by U.S. Food and Drug Administration (FDA) during a 510(k) premarket notification procedure. Link to the record in the FDA database: click here!

REQUEST a demo

Get in touch with us and let us show you how we can make X-ray angiography safer and more powerful with Kinepict.

By clicking “Request a demo” you accept our Privacy Policy.